Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
25.86
+0.20 (0.78%)
Dec 20, 2024, 4:00 PM EST - Market closed
Immunovant Employees
Immunovant had 207 employees as of March 31, 2024. The number of employees increased by 43 or 26.22% compared to the previous year.
Employees
207
Change (1Y)
43
Growth (1Y)
26.22%
Revenue / Employee
n/a
Profits / Employee
-$1,560,415
Market Cap
3.80B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| DENTSPLY SIRONA | 15,000 |
| ICU Medical | 14,000 |
| Organon & Co. | 10,000 |
| Option Care Health | 7,802 |
| Haemonetics | 3,657 |
| Sotera Health Company | 3,000 |
| Guardant Health | 1,779 |
| Prestige Consumer Healthcare | 570 |
IMVT News
- 10 days ago - FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Forecast to 2034 - Immunovant Advances FcRn Inhibitor Pipeline with Promising Results and FDA Green Light for Pivotal Trial - GlobeNewsWire
- 6 weeks ago - Immunovant Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 7 weeks ago - Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves' Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting - GlobeNewsWire
- 3 months ago - Top 2 Health Care Stocks That May Collapse This Quarter - Benzinga
- 3 months ago - Immunovant Provides Update on Graves' Disease Development Program - GlobeNewsWire
- 3 months ago - Immunovant to Host Graves' Disease Program Update on September 9, 2024 - GlobeNewsWire
- 4 months ago - Long Assets On Path To Creating Significant Value, Shorting Remains Very Challenging - Seeking Alpha
- 7 months ago - Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024 - GlobeNewsWire